Skip to end of metadata
  • Created by Former user , last modified by Former user on Jun 20, 2023
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 22 Next »

Project Scope 

  • Clarify definitions and labels.
  • Experience sharing of methodologies used to set thresholds for QTL parameters with a clear link to the scientific question of the clinical trial.
  • Develop a guidance for threshold-setting methodologies for QTL parameters with a clear link to the scientific question of the clinical trial.
Project LeadsEmail
Nathalie van Borrendam (Janssen Research & Development) nvanborr@its.jnj.com
Annett Keller (Boehringer Ingelheim) annett.keller@boehringer-ingelheim.com
Lauren White (PHUSE Project Coordinator) 

lauren@phuse.global 

Objectives & DeliverablesTimelines
Challenges in QTL threshold setting – Experience sharing and high-level recommendations for the industryQ3 2022

Guidance document on QTL threshold-setting methodologies

Q1 2023

CURRENT STATUS Q1 2023

Drafting of the white paper.
Project MembersOrganisations
Annett KellerBoehringer Ingelheim
Daniel Kowalski Clinscience
Debra JendrasekDaiichi Sankyo
Jim WangJanssen Research & Development
Marcus EeMaithy MuliMerck
Marion WolfsJanssen Research & Development
Marta KozińskaAstrazeneca
Nathalie van BorrendamJanssen Research & Development
Patrice BennerMerck
Stefano SainoMerck
Steve YoungCluePoints
Steven Andrew GilbertPfizer
Susan TalbotAmgen
  • No labels